Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Descriptive Pharmaco-epidemiological Study of a Hypertensive Patient Population Treated With a Fixed-dose Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg and of Conditions for the Management of Arterial Hypertension

NCT00909038 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT00909038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00909038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Descriptive Pharmaco-epidemiological Study of a Hypertensive Patient Population Treated With a Fixed-dose Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg and of Conditions for the Management of Arterial Hypertension
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
Not reported
Enrollment
2,411 (actual)
Sites
915

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension